Sundström E, Whittemore S, Mo L L, Seiger A
Department of Clinical Neuroscience and Family Medicine, Karolinska Institutet, KFC Novum, Huddinge, S-141 86, Sweden.
Exp Neurol. 1997 Dec;148(2):407-13. doi: 10.1006/exnr.1997.6691.
NMDA receptors in postmortem human spinal cord were analyzed using [3H]MK-801 ligand binding and immunoblotting with NMDA receptor subunit-specific antibodies. The average KD for [3H]MK-801 binding was 1.77 nM with a Bmax of 0.103 pmol/mg. The EC50 for stimulation of -3H-MK-801 binding with L-glutamate was 0.34 microM. None of these parameters were affected by postmortem intervals up to 72 h. Immunoblotting of native NMDA receptors showed that NR1, NR2A, NR2C, and NR2D subunits could all be found in the human spinal cord of which NR1 was preferentially located to the dorsal half. Immunoprecipitation of solubilized receptors revealed that NR1, NR2C, and NR2D subunits coprecipitated with the NR2A subunit, indicating that native human spinal cord NMDA receptors are heteroligimeric receptors assembled by at least three different receptor subunits. These results provide a basis for the development of drugs selectively aimed at spinal cord NMDA receptors for the future treatment of spinal cord disorders.
使用[3H]MK-801配体结合法以及针对NMDA受体亚基特异性抗体的免疫印迹法,对死后人类脊髓中的NMDA受体进行了分析。[3H]MK-801结合的平均解离常数(KD)为1.77 nM,最大结合容量(Bmax)为0.103 pmol/mg。L-谷氨酸刺激[3H]-MK-801结合的半数有效浓度(EC50)为0.34 microM。在长达72小时的死后间隔时间内,这些参数均未受到影响。对天然NMDA受体进行免疫印迹分析表明,NR1、NR2A、NR2C和NR2D亚基在人类脊髓中均能被检测到,其中NR1优先定位于背侧半部。对可溶受体进行免疫沉淀显示,NR1、NR2C和NR2D亚基与NR2A亚基共沉淀,这表明天然人类脊髓NMDA受体是由至少三种不同受体亚基组装而成的异源寡聚体受体。这些结果为未来开发针对脊髓NMDA受体的选择性药物以治疗脊髓疾病奠定了基础。